• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国感染发生率:主动监测与健康保险审查与评估服务国家数据的前瞻性研究。

Incidence of Infections in Republic of Korea: A Prospective Study With Active Surveillance vs. National Data From Health Insurance Review & Assessment Service.

机构信息

Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.

Department of Non-benefits Management, National Health Insurance Service, Wonju, Korea.

出版信息

J Korean Med Sci. 2024 Apr 1;39(12):e118. doi: 10.3346/jkms.2024.39.e118.

DOI:10.3346/jkms.2024.39.e118
PMID:
38565175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10985502/
Abstract

BACKGROUND

Since the emergence of hypervirulent strains of , the incidence of infections (CDI) has increased significantly.

METHODS

To assess the incidence of CDI in Korea, we conducted a prospective multicentre observational study from October 2020 to October 2021. Additionally, we calculated the incidence of CDI from mass data obtained from the Health Insurance Review and Assessment Service (HIRA) from 2008 to 2020.

RESULTS

In the prospective study with active surveillance, 30,212 patients had diarrhoea and 907 patients were diagnosed with CDI over 1,288,571 patient-days and 193,264 admissions in 18 participating hospitals during 3 months of study period; the CDI per 10,000 patient-days was 7.04 and the CDI per 1,000 admission was 4.69. The incidence of CDI was higher in general hospitals than in tertiary hospitals: 6.38 per 10,000 patient-days (range: 3.25-12.05) and 4.18 per 1,000 admissions (range: 1.92-8.59) in 11 tertiary hospitals, vs. 9.45 per 10,000 patient-days (range: 5.68-13.90) and 6.73 per 1,000 admissions (range: 3.18-15.85) in seven general hospitals. With regard to HIRA data, the incidence of CDI in all hospitals has been increasing over the 13-year-period: from 0.3 to 1.8 per 10,000 patient-days, 0.3 to 1.6 per 1,000 admissions, and 6.9 to 56.9 per 100,000 population, respectively.

CONCLUSION

The incidence of CDI in Korea has been gradually increasing, and its recent value is as high as that in the United State and Europe. CDI is underestimated, particularly in general hospitals in Korea.

摘要

背景

自从强毒力 菌株出现以来,感染(CDI)的发病率显著增加。

方法

为评估韩国 CDI 的发病率,我们进行了一项前瞻性多中心观察性研究,时间为 2020 年 10 月至 2021 年 10 月。此外,我们还根据 2008 年至 2020 年从健康保险审查和评估服务(HIRA)获得的大量数据计算了 CDI 的发病率。

结果

在有主动监测的前瞻性研究中,在 18 家参与医院的 3 个月研究期间,在 1288571 患者日和 193264 例住院中,30212 例患者出现腹泻,907 例患者被诊断为 CDI;每 10000 患者日的 CDI 为 7.04,每 1000 例住院的 CDI 为 4.69。综合医院的 CDI 发病率高于三级医院:11 家三级医院每 10000 患者日的 CDI 为 6.38(范围:3.25-12.05)和每 1000 例住院的 CDI 为 4.18(范围:1.92-8.59),而 7 家综合医院每 10000 患者日的 CDI 为 9.45(范围:5.68-13.90)和每 1000 例住院的 CDI 为 6.73(范围:3.18-15.85)。关于 HIRA 数据,所有医院的 CDI 发病率在 13 年期间一直在增加:每 10000 患者日从 0.3 增加到 1.8,每 1000 例住院从 0.3 增加到 1.6,每 100000 人口从 6.9 增加到 56.9。

结论

韩国的 CDI 发病率一直在逐渐增加,最近的值与美国和欧洲相当。在韩国,CDI 的发病率被低估了,特别是在综合医院。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd8/10985502/f843319aac8b/jkms-39-e118-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd8/10985502/70367d983336/jkms-39-e118-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd8/10985502/f843319aac8b/jkms-39-e118-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd8/10985502/70367d983336/jkms-39-e118-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd8/10985502/f843319aac8b/jkms-39-e118-g002.jpg

相似文献

1
Incidence of Infections in Republic of Korea: A Prospective Study With Active Surveillance vs. National Data From Health Insurance Review & Assessment Service.韩国感染发生率:主动监测与健康保险审查与评估服务国家数据的前瞻性研究。
J Korean Med Sci. 2024 Apr 1;39(12):e118. doi: 10.3346/jkms.2024.39.e118.
2
Surveillance and epidemiology of Clostridioides difficile infection using the national health surveillance network criteria: A 7-year study from Mumbai, India.利用国家卫生监测网络标准对艰难梭菌感染进行监测和流行病学研究:来自印度孟买的一项 7 年研究。
Indian J Med Microbiol. 2023 Nov-Dec;46:100425. doi: 10.1016/j.ijmmb.2023.100425. Epub 2023 Jul 12.
3
Cost and length of hospital stay for healthcare facilityonset Clostridioides Difficile infection in pediatric wards: a prospective cohort analysis.医疗机构相关性艰难梭菌感染患儿住院费用及住院时间的前瞻性队列分析。
Turk J Pediatr. 2021;63(6):1004-1011. doi: 10.24953/turkjped.2021.06.008.
4
Association between Antibiotic Consumption and Incidence of Infection in a Hospital.抗生素使用与医院感染发生率的关系。
J Korean Med Sci. 2020 Dec 7;35(47):e407. doi: 10.3346/jkms.2020.35.e407.
5
Increase of healthcare-onset Clostridioides difficile infection in adult population since SARS-CoV-2 pandemic: A retrospective cohort study in a tertiary care hospital from 2019 to 2022.自 SARS-CoV-2 大流行以来,成人 healthcare-onset 艰难梭菌感染增加:2019 年至 2022 年在一家三级保健医院进行的回顾性队列研究。
Anaerobe. 2024 Apr;86:102836. doi: 10.1016/j.anaerobe.2024.102836. Epub 2024 Feb 28.
6
Incidence and clinical features of Clostridium difficile infection in Korea: a nationwide study.韩国艰难梭菌感染的发生率和临床特征:一项全国性研究。
Epidemiol Infect. 2013 Jan;141(1):189-94. doi: 10.1017/S0950268812000581. Epub 2012 Apr 12.
7
Epidemiology of infections, France, 2010 to 2017.2010 年至 2017 年法国传染病的流行病学。
Euro Surveill. 2019 Aug;24(35). doi: 10.2807/1560-7917.ES.2019.24.35.1800638.
8
Factors Associated with Clostridioides (Clostridium) Difficile Infection and Colonization: Ongoing Prospective Cohort Study in a French University Hospital.与艰难梭菌(梭状芽孢杆菌)感染和定植相关的因素:法国某大学医院正在进行的前瞻性队列研究。
Int J Environ Res Public Health. 2021 Jul 15;18(14):7528. doi: 10.3390/ijerph18147528.
9
Incidence, epidemiology and control of infection in a tertiary care private hospital in India.印度一家三级私立医院感染的发病率、流行病学及控制情况
Indian J Med Microbiol. 2018 Jul-Sep;36(3):381-384. doi: 10.4103/ijmm.IJMM_18_340.
10
Multicenter study of Clostridium difficile infection rates from 2000 to 2006.多中心研究艰难梭菌感染率 2000 年至 2006 年。
Infect Control Hosp Epidemiol. 2010 Oct;31(10):1030-7. doi: 10.1086/656245.

引用本文的文献

1
Impact of Infection on Chemotherapy in Patients With Primary Ovarian Cancer.感染对原发性卵巢癌患者化疗的影响。
J Korean Med Sci. 2025 Aug 11;40(31):e179. doi: 10.3346/jkms.2025.40.e179.
2
The role of the enteric nervous system in the pathogenesis of Clostridioides difficile infection.肠道神经系统在艰难梭菌感染发病机制中的作用。
Nat Rev Gastroenterol Hepatol. 2025 May 22. doi: 10.1038/s41575-025-01071-x.
3
The Global Burden of Infections, 2016-2024: A Systematic Review and Meta-Analysis.2016 - 2024年全球感染负担:系统评价与荟萃分析

本文引用的文献

1
Does clinician-initiated Clostridioides difficile testing improve outcomes of patients with Clostridioides Difficile infection?临床医生主动进行艰难梭菌检测是否能改善艰难梭菌感染患者的结局?
Am J Infect Control. 2023 Oct;51(10):1085-1088. doi: 10.1016/j.ajic.2023.02.017. Epub 2023 May 11.
2
Trends in National Pharmaceutical Expenditure in Korea during 2011 - 2020.2011 - 2020年韩国全国药品支出趋势
Infect Chemother. 2023 Jun;55(2):237-246. doi: 10.3947/ic.2023.0028.
3
Nationwide Survey for Current Status of Laboratory Diagnosis of Infection in Korea.
Infect Dis Rep. 2025 Apr 14;17(2):31. doi: 10.3390/idr17020031.
4
Five-Day Treatment with Along with Classical Vancomycin Treatment Was Effective in Preserving Gut Microbiota in Patients with Infection.在感染患者中,与经典万古霉素治疗同时进行的五日治疗在保护肠道微生物群方面是有效的。
Nutrients. 2025 Feb 11;17(4):641. doi: 10.3390/nu17040641.
5
Attributable Costs of Infections in Korea.韩国感染的归因成本。
J Korean Med Sci. 2025 Feb 3;40(4):e22. doi: 10.3346/jkms.2025.40.e22.
6
Gut Microbiota and New Microbiome-Targeted Drugs for Infections.肠道微生物群与新型针对微生物群的抗感染药物
Antibiotics (Basel). 2024 Oct 20;13(10):995. doi: 10.3390/antibiotics13100995.
7
Demographic Characteristics and Economic Burden of Infection in Korea: A Nationwide Population-Based Study after Propensity Score Matching.韩国感染的人口统计学特征与经济负担:倾向得分匹配后的全国性基于人群的研究。
Antibiotics (Basel). 2024 Jun 10;13(6):542. doi: 10.3390/antibiotics13060542.
8
The Burden of Infection in Korea.韩国的感染负担。
J Korean Med Sci. 2024 Apr 1;39(12):e122. doi: 10.3346/jkms.2024.39.e122.
韩国感染症实验室诊断现状全国性调查。
J Korean Med Sci. 2022 Feb 7;37(5):e38. doi: 10.3346/jkms.2022.37.e38.
4
Geriatrics Fact Sheet in Korea 2021.《2021年韩国老年医学概况》
Ann Geriatr Med Res. 2021 Jun;25(2):65-71. doi: 10.4235/agmr.21.0063. Epub 2021 Jun 29.
5
Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.艰难梭菌感染(CDI)负担 - 原发性和复发性 CDI 流行病学的系统评价。
BMC Infect Dis. 2021 May 19;21(1):456. doi: 10.1186/s12879-021-06147-y.
6
Is bed turnover rate a good metric for hospital scale efficiency? A measure of resource utilization rate for hospitals in Southeast Nigeria.床位周转率是衡量医院规模效率的良好指标吗?尼日利亚东南部医院资源利用率的一项衡量指标。
Cost Eff Resour Alloc. 2020 Jul 1;18:21. doi: 10.1186/s12962-020-00216-w. eCollection 2020.
7
Trends in U.S. Burden of Infection and Outcomes.美国感染负担和结局的趋势。
N Engl J Med. 2020 Apr 2;382(14):1320-1330. doi: 10.1056/NEJMoa1910215.
8
Incidence and Outcomes Associated With Clostridium difficile Infections: A Systematic Review and Meta-analysis.艰难梭菌感染的发生率和结局:系统评价和荟萃分析。
JAMA Netw Open. 2020 Jan 3;3(1):e1917597. doi: 10.1001/jamanetworkopen.2019.17597.
9
infection in the Asia-Pacific region.亚太地区的感染情况。
Emerg Microbes Infect. 2019 Dec 24;9(1):42-52. doi: 10.1080/22221751.2019.1702480. eCollection 2020.
10
Regional differences in temporal incidence of Clostridium difficile infection: a systematic review and meta-analysis.区域间艰难梭菌感染时间发病差异:系统评价和荟萃分析。
Am J Infect Control. 2020 Jan;48(1):89-94. doi: 10.1016/j.ajic.2019.07.005. Epub 2019 Aug 3.